The influence of papillary features on the risk of malignancy in thyroid nodules diagnosed as atypia of undetermined significance or follicular lesion of undetermined significance - 02/05/23
Abstract |
Background |
The objective of this study was to the assess the risk of malignancy in thyroid lesions that were diagnosed as AUS/FLUS when using a novel cytology subclassification system that is based on the presence or absence of papillary features.
Methods |
AUS/FLUS case cytology was re-reviewed and subclassified into minor or major concern groups based upon the absence or presence of papillary features, respectively. The risk of malignancy (ROM) was calculated and compared between the two groups. Inter-pathologist agreement in case subclassification was also measured.
Results |
The minor concern group had a 12.6% associated ROM, while the major concern group had a significantly higher ROM (58.4%), (P < 0.001). Based on 108 cases, the inter-pathologist agreement in case subclassification was 79%, and the κ value was 0.47.
Conclusions |
The identification of papillary features significantly increases the ROM in thyroid lesions with an AUS/FLUS diagnosis.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Highlights |
• | AUS/FLUS thyroid nodules were subclassified into major or minor concern of cancer. |
• | Risk of malignancy in the major vs. minor concern group was 58.4% vs. 12.6% (P-value <0.001). |
• | Inter-pathologist agreement for subclassifying AUS/FLUS nodules was 79%, and the κ value = 0.47. |
• | Subclassifying AUS/FLUS cases allows for better preop thyroid nodule cancer risk estimation. |
Keywords : Thyroid cytology, Fine needle aspiration biopsy, Atypia of undetermined significance, Follicular lesion of undetermined significance, Malignancy risk
Plan
Vol 225 - N° 5
P. 857-860 - mai 2023 Retour au numéro
Article précédent
- Use of dual energy computed tomography versus conventional techniques for preoperative localization in primary hyperparathyroidism: Effect of preoperative calcium and parathyroid hormone levels
- Michael Guo, Daniel B. Lustig, Debon Lee, Neraj Manhas, Sam M. Wiseman
- Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer
- Thomas L. Sutton, Ranish Patel, Shay Behrens, Issac Schwantes, Connor Fewel, Stuart K. Gardiner, Nathalie Johnson, Jennifer R. Garreau
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?